CEOCFO Magazine Interviewed Aclipse Therapeutics CEO Raymond Houck

blue bubbles flowing in space

CEOCFO Magazine has interviewed Aclipse Therapeutics CEO Raymond Houck. Mr. Houck has introduced the background of the company and our lead drug product M102. He has also described the target pathomechanisms of M102 and its precision medicine approach to ALS and CNS diseases.

We're here to answer any questions.
Looking to connect with us?